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Summary
In spondylocostal dysostosis (SD), vertebral-segmenta-
tion defects are associated with rib anomalies. This re-
sults in short-trunk short stature, nonprogressive ky-
phoscoliosis, and radiological features of multiple
hemivertebrae and rib fusions. SD can be familial, and
both autosomal dominant and autosomal recessive (AR)
inheritance have been reported, but no genes have been
identified or localized for nonsyndromic SD in humans.
We performed genomewide scanning by homozygosity
mapping in a large consanguineous ARSD Arab Israeli
family with six definitely affected members. Significant
linkage was found to chromosome 19q13, with a LOD
score of 6.9. This was confirmed in a second Pakistani
family with three affected members, with a LOD score
of 2.4. The combined-haplotype data identify a critical
region between D19S570 and D19S908, an interval of
8.5 cM on 19q13.1-19q13.3. This is the first study to
localize a gene for nonsyndromic SD. ARSD is clinically
heterogeneous and is likely to result from mutations in
developmental genes or from regulating transcription
factors. Identification of these genes will improve the
understanding of the molecular processes contributing
to both normal and abnormal human vertebral
development.
Introduction
Spondylocostal dysostosis (SD; MIM 277300) is the as-
sociation of multiple vertebral-segmentation defects with
rib anomalies. This results in a short-trunk short-stature
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syndrome, with nonprogressive kyphoscoliosis and ra-
diological appearances of a variable degree of multiple
hemivertebrae. The involvement of the thoracic spine
leads to irregular rib alignment and points of fusion, and
occasionally ribs are absent. SD can be either sporadic
(Mortier et al. 1996) or familial. Monogenic SD families
have been reported, with both autosomal dominant
(AD) (Rimoin et al. 1968; Temple et al. 1988; Floor et
al. 1989; Lorenz and Rupprecht 1990) and autosomal
recessive (AR) inheritance (Norum and McKusick 1969;
Cantu´ et al. 1971; Castroviejo et al. 1973; Franceschini
et al. 1974; Silengo et al. 1978; Beighton and Horan
1981; Turnpenny et al. 1991; Satar et al. 1992). Asso-
ciated features in familial SD include anal and urogenital
anomalies (Casamassima et al. 1981), congenital heart
disease (Delgoffe et al. 1982; Aurora et al. 1996), limb
abnormalities (Wadia et al. 1978), plagiocephaly-torti-
collis sequence (Turnpenny et al. 1991), and inguinal
hernias in male patients (Bonaime et al. 1978; Turn-
penny et al. 1991), but with no neurological signs or
mental retardation. In sporadic cases, clinical features
are very heterogeneous, and malformations beyond the
vertebrae and ribs are more common (Kozlowski 1984;
Martı´nez-Frı´as et al. 1994; Mortier et al. 1996).
Terminology in the literature for anomalies of spinal
development is potentially confusing because multiple
names have been used for similar clinical syndromes.
“Spondylothoracic dysostosis” has been used for the se-
vere and often lethal AR form, which presents a crablike
chest on radiograph—the Jarcho-Levin syndrome (Jar-
cho and Levin 1938; Ayme´ and Preus 1986)—but also
sometimes has been used for the mild AR form (similar
to the phenotypes seen in families of this study). “Spon-
dylocostal dysostosis” has been reserved by some (Mor-
tier et al. 1996) for AD families, in which the phenotype
is generally mild, but has also been used for the mild
AR form (Roberts et al. 1988). The term “costovertebral
dysplasia” features in earlier reports (Noram and
McKusick 1969; Cantu´ et al. 1971; Bartsocas et al.
1974; David and Glass 1983).
Vertebral-segmentation defects are a feature of nu-
merous syndromes and genetic conditions, including
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Klippel-Feil syndrome, Goldenhar syndrome, X-linked
dominant incontinentia pigmenti, and the VATER (ver-
tebral defects, anal atresia, tracheo-esophageal fistula,
radial defects and renal anomalies) and VACTERL (ver-
tebral defects, anal atresia, cardiac defects, tracheo-
esophageal fistula, radial defects and renal anomalies,
nonradial limb defects) associations. Vertebral anoma-
lies have also been associated with chromosome abnor-
malities (Crow et al. 1997; Dowton et al. 1997), in-
cluding trisomy 8 mosaicism (Riccardi 1977) and an
apparently balanced 14;15 chromosome translocation
(De Grouchy et al. 1963).
The genes and genetic loci for nonsyndromal SD are
unknown. Genes have been cloned for two monogenic
conditions that include vertebral-segmentation defects as
a feature: Alagille syndrome (jagged-1, chromosome
20p12) and Simpson-Golabi-Behmel syndrome (glypi-
can 3, chromosome Xq26). In both cases the vertebral
abnormalities are minor compared with those associated
with SD, which is therefore phenotypically very differ-
ent. The closest animal models to SD are the undulated
mouse, in which vertebral abnormalities occur because
of mutations in Pax-1 (Balling 1994), and the pudgy
(pu) homozygous mouse, in which vertebral abnormal-
ities occur because of mutations in Dll3 (Kusumi et al.
1998). The human homologues for Pax-1 and Dll3 are
located on chromosomes 20p11.2 and 19q13.2-q13.3,
respectively (Giampietro et al. 1999). To date, no human
disease associated with mutations in Pax-1 is known,
and mutations have not been found in cases of Klippel-
Feil syndrome (Smith and Tuan 1994).
The availability of a large inbred family with ARSD,
first reported by Turnpenny et al. (1991), has made it
possible to begin to elucidate the molecular genetics of
SD in humans by homozygosity mapping using a DNA-
pooling strategy and genomewide screening. An addi-
tional consanguineous SD family has also been recruited.
Their phenotypes are described and illustrated, and the
results of linkage analysis are presented.
Families and Methods
Families
We performed genomewide scanning by homozygos-
ity mapping in a large consanguineous ARSD Arab-Is-
raeli family with six definitely affected members. An ad-
ditional consanguineous SD family was also recruited.
The pedigrees of family 1 and family 2 are shown in
figures 1 and 2, respectively.
Family 1.—Family 1 is a large inbred Arab-Israeli kin-
dred with six living affected individuals and one de-
ceased individual in three disparate branches, first re-
ported by Turnpenny et al. (1991) (fig. 1). The family
is highly consanguineous, but the exact relationships to
a single common ancestor are no longer known. The
chest radiographs of the index case (individual VI-1) at
age 2.5 years and of an affected adult at age 31 years
(individual V-18) are shown in figure 3A and B, respec-
tively. Involvement of the spine in all the affected cases
is extensive, and there is consistency in the malsegmen-
tation pattern, throughout the length of the vertebral
column. Most of the affected male subjects have uni-
lateral or bilateral inguinal hernias, which have required
surgical repair. They had no neurological signs, and renal
ultrasound in all cases studied was normal. The family
was revisited and blood samples, for DNA extraction,
were taken from the 6 living affected cases, 9 obligate
carriers, and 13 individuals at high-carrier risk. The af-
fection status of a seventh individual, V-8, was uncertain
because of very mild vertebral abnormalities, consisting
of mid-thoracic scoliosis (fig. 3C) without segmentation
defects and lower-lumbar spinal abnormality (fig. 3D),
apparently with a segmentation defect. She showed a
plagiocephaly-torticollis sequence, and the clinical im-
pression was of an individual likely to be homozygous
for the putative gene mutation but demonstrating a very
mild phenotype.
Family 2.—Family 2 (fig. 2) is a nuclear consanguin-
eous family originating from the Rawalpindi area of
Pakistan. They are believed to be descended from Mo-
ghuls 600 years ago and have no known connections
with migrations of Arabs from the Middle East. They
consist of second-cousin parents with three affected and
two unaffected children. Their phenotype is very similar
to that of family 1 (fig. 3E), with the most severe seg-
mentation defects, in individual V-5, seen in the thoracic
region. Clinically, the affected individuals manifest a
short-trunk form of dwarfism. The affected male subject
did not have hernias, and renal ultrasonography has not
been performed.
Initial Genomewide Screen
To rapidly screen for markers linked to the disease,
we adopted an initial DNA-pooling strategy. This strat-
egy takes advantage of the likelihood that affected in-
dividuals in inbred families share a common chromo-
somal region inherited from a common ancestor (Lander
and Botstein 1987). A pool of DNA samples from the
seven affected members of family 1 were used as tem-
plates for the amplification of genomewide markers.
With use of this approach, markers linked with the dis-
ease phenotype show a shift in allele frequencies, toward
a single homozygous allele in the affected DNA pool.
Pooling of DNA
DNA was extracted from samples of peripheral blood,
by standard methods. The DNA concentrations were
determined by spectrophotometric measurements at
OD260. DNA samples were diluted to 50 ng/ml, and
individual DNA samples from the affected members of
Figure 1 Pedigree of family 1, with genotypes for 17 DNA markers from chromosome 19q13. A question mark (?) within a haplotype indicates genotypes that were not determined. Regions
of homozygosity are indicated by blackened bars. Affected and unaffected individuals are represented by blackened and unblackened symbols, respectively. The uncertainty about the affected status
of individual V-8 is indicated by a question mark (?). Double lines indicate consanguineous marriages. The precise relationships of generations I–III are no longer known; the simplest ancestry is
therefore shown.
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Figure 2 Pedigree of family 2, with genotypes for 18 DNA mark-
ers from chromosome 19q13. Regions of homozygosity are indicated
by blackened bars. Affected and unaffected individuals are represented
by blackened and unblackened symbols, respectively. Double lines in-
dicate consanguineous marriages.
family 1 were tested in PCR assays to demonstrate equal
amplification between samples prepared from different
individuals. The affected pool from family 1 consisted
of seven DNA samples (from individuals V-8, V-17, V-
18, V-19, VI-1, VI-3, and VI-4) at a final concentration
of 50 ng/ml.
Genotyping
Pooled DNA from the seven affected individuals from
family 1 was used for the initial genome screen. This
was performed with 343 autosomal markers, from the
Perkin-Elmer Biosystems Linkage Mapping Set (version
1). These markers are spaced at ∼10-cM intervals and
have an average heterozygosity of .8. Forward primers
are labeled with either 6-FAM, HEX, or TET fluorescent
dyes, which allows multiplex analysis to be done on an
ABI 377 DNA sequencer. The reverse primers have a
5′GTTT “PIGtail,” which has been shown to facilitate
185% addition of the nucleotide adenosine to the 3′ end
of the forward product (Brownstein et al. 1996). PCR
reactions were performed with 75 ng pooled DNA in a
7.5-ml PCR reaction mixture containing 2.5 pmol each
primer, 200 mM each dNTP, 50 mM KCl, 10 mM Tris-
HCl (pH 8.3), 2.5 mM MgCl2, and 0.3 U AmpliTaq
Gold (Perkin-Elmer Applied Biosystems). Reactions
were performed in 96-well microtiter plates, and am-
plification was performed on a Perkin-Elmer model
9600, with an initial denaturation step of 12 min at
95C; this was followed by 10 cycles of 94C for 15 s,
55C for 15 s, and 72C for 30 s; then by 20 cycles of
89C for 15 s, 55C for 15 s, and 72C for 30 s; and
then by 72C for 10 min. PCR products were pooled in
a 1:2:1 ratio of 6-FAM:HEX:TET–labeled products and
then were mixed with formamide, GS-500 size standard
(Perkin-Elmer Applied Biosystems), and Blue dextran
(Perkin-Elmer Applied Biosystems). The products were
separated, by electrophoresis, onto 4% (w/v) denaturing
polyacrylamide gels, on an ABI 377 DNA sequencer.
GENESCAN ANALYSIS 2.1 and GENOTYPER 2.0
software were used to size PCR products and analyze
data.
The affected subjects were analyzed separately for all
markers at which two or more alleles in the pooled sam-
ple were not clearly identified. When individual analysis
of affected individuals showed widespread homozygos-
ity, the whole family was analyzed, to establish whether
there was homozygosity by descent with carriers being
heterozygous.
Confirmation of Region of Homozygosity
After a potential region of homozygosity was identi-
fied, additional markers were selected from the Ge´ne´-
thon. This region was then tested in both families. Hap-
lotype analysis in these linked families was done to define
the localization of the gene.
Linkage Analysis
Two-point linkage analysis, between affected status
and the haplotype apparently segregating with the dis-
ease, was done with the MLINK program (version 5.2)
of the LINKAGE package. For these analyses, an AR
mode of inheritance and a disease-allele frequency of
.0001 were used. The frequency of the haplotype ap-
parently segregating with the disease was assumed to be
.1; this represents a highly conservative estimate, given
the number (10) of markers homozygous in this region
and their informativity (∼0.8% heterozygosity).
Results
Initial Screen
In the initial screen of pooled DNA from family 1,
two or more alleles were not clearly identified for 44 of
the 343 markers. These 44 markers were investigated
further by genotyping the individual DNA from the
seven affected members of family 1. The seven affected
subjects were not homozgous for a single allele, with
any marker. However, six of the seven affected individ-
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Figure 3 A, Radiograph of the spine of individual VI-1 (family 1), at age 2.5 years. Extensive malsegmentation of the vertebrae throughout
the spinal column is present, with scoliotic curves. There are 11 pairs of ribs and multiple points of fusion. B, Radiograph of the spine of
individual V-18 (family 1), at age 31 years. Extensive malsegmentation is present, giving rise to a nonprogressive scoliotic deformity.C,Radiograph
of the thoracic spine of individual V-8 (family 1), at age 15 years. Two mild scoliotic curves are present, apparently without a segmentation
defect. There are no points of rib fusion. D, Radiograph of the lumbar spine of individual V-8 (family 1), at age 15 years. Segmentation defects
appear to affect L4–S1. E, Radiograph of individual V-5 (family 2), in the neonatal period. Vertebral-segmentation defects are most severe in
the cervical and thoracic regions.
uals were homozygous for five markers (D6S462,
D10S548, D14S276, D14S78, and D19S220). The un-
affected family members were then genotyped for these
five markers, to identify linkage to the disease phenotype
rather than homozygosity due to the presence of com-
mon alleles. D19S220 was the only marker that showed
homozygosity by descent in all affected individuals—
except for V-8, who shows a markedly milder phenotype
compared with those in her affected relatives. Individual
V-8 and all obligate carriers were heterozygous for
D19S220. Additional markers close to D19S220 were
typed, and a homozygous region was identified between
D19S425 and D19S412 (fig. 1). The distance between
these markers is 11.2 cM. A maximum LOD score of
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Figure 4 Genetic map and distances of chromosome 19 markers.
The location of the SD gene is determined on the basis of the region
of homozygosity in families 1 and 2.
8.9 at a recombination fraction of 0 was calculated, with
the assumption that individual V-8 is of “unknown”
affected status. We obtained this value by dividing the
family into two separate parts and summing the two
resulting LOD scores, since the presence of multiple con-
sanguineous loops imposes computational limits. This
value therefore represents a conservative estimate. As
expected, the LOD score was sensitive to the given hap-
lotype frequency, although the evidence for linkage in
this family remained strong for a wide range of fre-
quencies—LOD scores of 5.9, 6.9, and 8.9 were ob-
tained for linked-allele frequencies of .2, .1 and .01,
respectively.
Confirmation of Linkage to 19q
Linkage of SD to the candidate region on chromosome
19q was confirmed in family 2. The three affected sub-
jects (V-1, V-3, and V-5) of family 2 were homozygous
for markers D19S876–D19S902 (fig. 2). The LOD score
in this family was 2.4 with a haplotype frequency of .1
and was 3.0 with a frequency of .01. The linked hap-
lotype was different from that of family 1. Haplotype
analysis of the two families allowed the genetic interval
to be narrowed to an 8.5-cM region, between markers
D19S570 and D19S412 (fig. 4).
Discussion
We have localized the first gene for nonsyndromic SD,
using homozygosity mapping. We have shown signifi-
cant linkage, in two unrelated pedigrees with ARSD, to
an 8.5-cM region on chromosome 19q13.1-q13.3.
DNA linkage mapping by homozygosity of descent in
inbred kindreds with AR conditions is now a well-es-
tablished strategy for the localization of genes causing
distinctive phenotypes or disease (Lander and Botstein
1987; Gelb et al. 1995). It is especially powerful when
multiple affected individuals are present in disparate
branches of a large kindred, such as in family 1 in this
study. In genomewide screening, only one region of ho-
mozygosity was identified, in all six clearly affected in-
dividuals, with obligate carriers demonstrating hetero-
zygosity. Individual V-8, with mild vertebral changes (fig.
3B and C), appears to be a heterozygous carrier. Since
all obligate carriers, when studied, had radiologically
normal spines, her scoliosis may have a different etiol-
ogy, or it may be that she is a manifesting carrier for
ARSD.
In family 2 there was also linkage to the 19q13 locus,
with a significant LOD score independent of that in fam-
ily 1. Haplotype analyses for these two families confirm
that a gene for ARSD lies between markers D19S570
and D19S412, a critical region of 8.5 cM. Distinct hap-
lotypes in the region of interest in these two families
refutes the possibility of a founder effect—which is not
surprising given their ethnic diversity.
The nature of the phenotype in SD suggests an alter-
ation in either a developmental gene or a regulating tran-
scription factor. In humans, vertebrae develop, at 3.5–6
wk of embryonic life, from the somites, after differen-
tiation into dermatome, myotome, and sclerotome.
Sclerotomic cells spread out to form a perichordal
sheath. Dense and loose areas develop in both the scler-
otome and perichordal sheath, from which the central
dense area gives rise to the intervertebral disks, the pe-
ripheral dense area gives rise to the neural process of
the vertebra and rib, and the loose central zone forms
the vertebral column. Altered regulation of cell signaling,
during what is normally an ordered and precise sequen-
tial process of cellular differentiation, presumably gives
rise to irregularly shaped vertebrae, or hemivertebrae,
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and rib anomalies. Although these processes must be
subject to a variety of developmental insults, as evi-
denced by the range of distinct syndromes causing seg-
mentation defects, the relative paucity of associated mal-
formations in the monogenic forms of SD suggests an
alteration, in gene expression, that is very localized and
time limited. It is logical to implicate elements within
the equivalent of the “vertebral column hox code,”
which has been elucidated in the mouse (Kessel 1991;
Horan et al. 1995), or, possibly, within other develop-
mental genes, such as pax or pou. Chromosome 19q13
is a gene-rich region of the genome, which contains a
large number of expressed sequence tags (ESTs): 273
ESTs between markers D19S228 and D19S219, accord-
ing to the GB4 map (GeneMap). However, the identi-
fication of Dll3 in the pudgy homozygous mouse (Ku-
sumi et al. 1998), whose human homologue is located
at 19q13.2-q13.3 (Giampietro et al. 1999), makes this
a strong candidate gene. Pudgy mice have severe ver-
tebral and rib deformities, thus demonstrating a phe-
notype that is close to ARSD in humans. Dll3 is ho-
mologous to the Notch-ligand Delta in Drosophila
melanogaster and is involved both in the developmental
integrity of early somite formation and the patterning
of vertebrate paraxial mesoderm. Identification of the
gene(s) and disease-causing mutations in families with
Mendelian forms of SD will ultimately lead to an im-
proved understanding of the molecular processes that
give rise to normal and abnormal development of the
spine.
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